Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect Study of Rezatapopt (PC14586) in Healthy Volunteers
NCT05249348Phase 1Completed
- Sponsor
- PMV Pharmaceuticals, Inc.
- Start
- Dec 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rezatapopt in solid tumor (5 arms), sponsored by PMV Pharmaceuticals, Inc. Primary endpoints: Area Under the Concentration-Time Curve from time zero to the last measurable concentration at 2 months, Area Under the Concentration-Time Curve from time zero to infinity at 2 months and 2 more. Started Dec 2021; status: completed.
02
Drugs
rezatapopt
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05249348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05249348.